Manager, Gene Therapy
World Federation of Hemophilia, Canada
Mayss Naccache is currently sector Head, Gene Therapy Program within the Research & Education department of the World Federation of Hemophilia. Since joining the WFH in 2017, Mayss managed the successful launch of the World Bleeding Disorders Registry, the development of the Gene Therapy registry, and the organization of the Gene Therapy Round Table series and Global Forum meetings. Mayss has over 15 years of experience managing global research initiatives in non-profit, governmental, and academic settings. Mayss holds a Master of Business Administration degree and a Master’s in Genetics.
Disclosure information not submitted.
Ensuring Patient Registries Support Regulatory Decision-Making
Wednesday, October 4, 2023
3:30 PM – 4:30 PM EDT